• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.


(CAS: 807640-87-5)

Suppliers of BGB-102

Company Name Email Tel Country
BOC Sciences [email protected] 1-631-504-6093

Fax: 1-631-614-7828Purity: Brand: BOC Sciences

CHEMSCENE, LLC [email protected] 732-484-9848 USA

Fax: 888-484-5008Purity: Brand:

Price and Availability: USD1536/1mg () USD3072/5mg ()

MedChemexpress Co., Ltd. [email protected] 609-228-6898 USA

Fax: 609-228-5909Purity: Brand:

Price and Availability: USD1536/1mg () USD3072/5mg ()

MedKoo Biosciences, Inc. [email protected] 919-279-0682 USA

Fax: 919-980-4831Purity: >98% Brand:

Shanghai Haoyuan Chemexpress Co., Ltd. [email protected] +86 (21) 5187-0955 / +86 (21) 5895-5995 China

Fax: +86 (21) 5895-5996Purity: Brand:

Price and Availability: USD1536/1mg () USD3072/5mg ()

Inquiry Online

Salutation: *Country:
*Customer: *Company Name:
*Email: *Request quantity:

Notice: Your contact information will be sent to selected suppliers.

* Required Fields.

Background Information of BGB-102

BGB-102 is a potent multi-kinase inhibitor against EGFR, HER2, and HER4 with IC50s of 9.6 nM, 18 nM and 40.3 nM, respectively.

Solubility of BGB-102

Solubility Sources
Soluble in DMSO, not in water MedKoo Biosciences, Inc.

Storage Condition of BGB-102

Storage Condition Sources
Storage condition:Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). Stock solution storage:0 - 4 C for short term (days to weeks), or -20 C for long term (months). Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. MedKoo Biosciences, Inc.

MSDS Information

MSDS Sources

Quality Control and Spectral Data

QC Reports Sources

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
BGB-102 Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Janssen Pharmaceutica N.V., Belgium Protein Kinase Inhibitors|Antineoplastic Protocols|Clinical Trial, Phase 1|Maximum Tolerated Dose|Pharmacokinetics|Advanced Malignancies|Solid Malignancies 2006/8/01 Phase 1

Chemical Information

M.Wt Formula CAS No. Synonyms
457.36 C22H25BrN4O2 807640-87-5 JNJ-26483327;BGB102;BGB 102;JNJ26483327;JNJ 26483327;

Structure Information of BGB-102

Smiles CN1CCCCCOC(C(OC)=C2)=CC3=C2N=CN/C3=NC4=CC(Br)=CC=C4C1
InChI InChI=1S/C22H25BrN4O2/c1-27-8-4-3-5-9-29-21-11-17-19(12-20(21)28-2)24-14-25-22(17)26-18-10-16(23)7-6-15(18)13-27/h6-7,10-12,14H,3-5,8-9,13H2,1-2H3,(H,24,25,26)

Related Products

Other Form Products of BGB-102

Name CAS Formula Suppliers

Recommended Products in Same Target

Name CAS Formula Suppliers
Ginsenoside Rh2 78214-33-2 C36H62O8 7
Mutated EGFR-IN-1 1421372-66-8 C25H31N7O 7
AZD-9291 (mesylate) 1421373-66-1 C29H37N7O5S 6
Mutant EGFR inhibitor 1421373-62-7 C27H30ClN7O2 6
AZD-9291 1421373-65-0 C28H33N7O2 18
WHI-P180 (hydrochloride) 153437-55-9 C16H16ClN3O3 5
WHI-P180 211555-08-7 C16H15N3O3 7
Gefitinib (hydrochloride) 184475-55-6 C22H25Cl2FN4O3 7
Erlotinib (mesylate) 248594-19-6 C23H27N3O7S 5
Poziotinib 1092364-38-9 C23H21Cl2FN4O3 12
CO-1686 (hydrobromide) 1446700-26-0 C27H29BrF3N7O3 11
CO-1686 1374640-70-6 C27H28F3N7O3 12
CNX-2006 1375465-09-0 C26H27F4N7O2 10
PD168393 194423-15-9 C17H13BrN4O 13
AG 18 118409-57-7 C10H6N2O2 16
Afatinib (dimaleate) 850140-73-7 C32H33ClFN5O11 11
Chrysophanol 481-74-3 C15H10O4 19
AG-1478 153436-53-4 C16H14ClN3O2 12
Mubritinib 366017-09-6 C25H23F3N4O2 24
AST-1306 (TsOH) 1050500-29-2 C31H26ClFN4O5S 13

Recommended Products in the Same Indication

Name CAS Formula Suppliers

Chemical and Physical Properties

Appearance: Melting point:
Boiling point: Flash Point:
Water Solubility: Solubility:
Density: Merck:
BRN: Refractive Index:
Vapour: EINECS:
Optical Rotation: alpha:


Tags: buy BGB-102 | BGB-102 IC50 | BGB-102 price | BGB-102 cost | BGB-102 solubility | BGB-102 purchase | BGB-102 manufacturer | BGB-102 research buy | BGB-102 order | BGB-102 MSDS | BGB-102 chemical structure | BGB-102 Storage condition | BGB-102 molecular weight | BGB-102 mw | BGB-102 datasheet | BGB-102 supplier | BGB-102 cell line | BGB-102 NMR | BGB-102 MS | BGB-102 IR | BGB-102 solubility | BGB-102 Safe information | BGB-102 Qc and Spectral Information | BGB-102 Clinical Information | BGB-102 Clinical Trial | BGB-102 Route of Synthesis | BGB-102 storage condition | BGB-102 diseases and conditions | BGB-102 flash point | BGB-102 boiling point | BGB-102 melting point | BGB-102 storage condition | BGB-102 brand